Biomechanical Characterization of the Locomotion in Multiple Sclerosis Patients
NCT ID: NCT03756142
Last Updated: 2024-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2018-11-19
2020-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
85 % of the MS patients report gait disorders, which impact their autonomy and their quality of life and increase the risk of fall.
The three-dimensional analysis of the walking by a motion capture system associated with force platforms allows the quantification of the complex walking disorders, to look for the cause, as well as side effects such as compensation strategies.
According to the 2006 report of the French National Authority for Health, the 3D analysis of walking is essential in chronic pathologies to evaluate and quantify gait disorders. This analysis allows the functional follow-up of the patients throughout their rehabilitation. Some studies, on a small and heterogeneous population of MS patients, showed changes during the walking concerning spatiotemporal, kinematic, dynamic parameters and muscular activation of lower limbs at early stages of the disease. Only two studies evaluate the joint power during walking in MS patients. However, these studies have some limits.
The 3D analysis of the walking proposed in this study would allow the biomechanical characterization of the gait impairments of MS patients through tasks such as walking, gait initiation and orthostatic posture. This methodology would contribute to adapt treatments and the rehabilitation care, at an early stage of the disease.
From a functional point of view, the gait initiation is an interesting dynamic task to be evaluated. Indeed, it represents the transition between the upright posture and the stabilized walking. Throughout this complex task, a stereotypical motor program is set up during a first phase of anticipatory postural adjustments, which allows the creation of dynamic conditions essential for the execution of the first step. The gait initiation is little documented for MS patients despite the risk of fall clinically highlighted. The articular power during the gait initiation was never estimated in MS patients. On the other hand, there is no study establishing correlations between the Expanded Disability Status Scale functional features and the impairments of the gait initiation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury
NCT06107556
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting
NCT06261541
Multi-joint Muscle Fatigability and Gait Performance in People With Multiple Sclerosis
NCT03735654
Locomotor Training in Persons With Multiple Sclerosis
NCT00607126
Interoception and Sense of Movement in the Patient With Multiple Sclerosis
NCT03711968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multiple sclerosis patients
Analysis of orthostatic posture, initiation of walking and walking in MS patients with an EDSS between 0 and 4 (included) by a motion analysis system
Motion Analysis
Analysis of orthostatic posture, initiation of walking and walking by a motion analysis system
Healthy volunteers
Analysis of orthostatic posture, initiation of walking and walking in a group of healthy volunteers
Motion Analysis
Analysis of orthostatic posture, initiation of walking and walking by a motion analysis system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motion Analysis
Analysis of orthostatic posture, initiation of walking and walking by a motion analysis system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable disease for at least 6 weeks
* No injection of botulinum toxin in the past 4 months
Exclusion Criteria
* Disabling pathologies of the locomotor apparatus
* Non-stabilized Respiratory, Cardiovascular disease
* Pregnant or breastfeeding women
* Patient with cognitive impairment
* Recent modification of MS treatment (\<3 months)
* Neurological disease
* Rheumatological disease
* Sprain of the lower limbs in the last 3 months
* Fracture of the lower limbs in the last year
* Pregnant or breastfeeding women
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoire d'Automatique, de Mécanique et d'Informatique Industrielles et Humaines
UNKNOWN
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline Massot, MD
Role: PRINCIPAL_INVESTIGATOR
GHICL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Saint-Philibert
Lomme, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P0067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.